Bexxar tositumomab radiolabeled monoclonal antibody regulatory update

CLTR received U.S. Patent No. 6,015,542 covering radiolabeled monoclonal antibodies that target the CD20 antigen on the surface of B cells to treat B cell lymphomas. ...